Literature DB >> 11809430

Role of cyclooxygenase products in the regulation of vascular tone and in the endothelial vasodilator function of normal, hypertensive, and hypercholesterolemic humans.

Umberto Campia1, Wassim K Choucair, Melissa B Bryant, Arshed A Quyyumi, Carmine Cardillo, Julio A Panza.   

Abstract

A defective vascular activity of endothelial vasoactive substances is observed in essential hypertension and hypercholesterolemia, and is believed to participate in the vascular abnormalities characteristic of these conditions. The present study aimed to determine the role of cyclooxygenase (COX) products in the maintenance of vascular tone and in the endothelium-mediated vasodilation of healthy subjects, and to investigate their contribution to the endothelial dysfunction of essential hypertensive and hypercholesterolemic patients. The effects of intra-arterial aspirin (acetylsalicylic acid [ASA], 1, 3, and 10 mg/min) were assessed on basal forearm blood flow (strain gauge plethysmography) and on responses to acetylcholine (7.5, 15 and 30 microg/min) and sodium nitroprusside (0.8, 1.6 and 3.2 microg/min) in 24 normal, 23 hypertensive, and 24 hypercholesterolemic subjects. Basal forearm blood flow was not different among the 3 groups (p = 0.95). ASA resulted in a significant reduction of forearm blood flow from baseline in normal (p = 0.003), hypertensive (p = 0.001), and hypercholesterolemic subjects (p = 0.001), without any difference among the 3 groups (p = 0.90). ASA significantly improved the effect of acetylcholine in normal (p = 0.008), hypertensive (p = 0.008), and hypercholesterolemic subjects (p = 0.022), without significant difference among the 3 groups (p = 0.46). ASA did not significantly modify the vasodilator effect of sodium nitroprusside in any of the 3 groups. These findings suggest that in humans, vasodilator prostanoids actively contribute to the maintenance of basal vascular tone, whereas vasoconstrictor products of COX activity limit endothelium-dependent vasodilation. COX products do not appear to play a major role in the endothelial dysfunction of hypertensive or hypercholesterolemic patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11809430     DOI: 10.1016/s0002-9149(01)02229-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  Endothelium-derived hyperpolarizing factor determines resting and stimulated forearm vasodilator tone in health and in disease.

Authors:  Muhiddin A Ozkor; Jonathan R Murrow; Ayaz M Rahman; Nino Kavtaradze; Ji Lin; Amita Manatunga; Arshed A Quyyumi
Journal:  Circulation       Date:  2011-05-09       Impact factor: 29.690

Review 2.  Anti-inflammatory strategies in hypertension: focus on COX-1 and COX-2.

Authors:  Matthias Hermann; Frank Enseleit; Frank T Ruschitzka
Journal:  Curr Hypertens Rep       Date:  2005-02       Impact factor: 5.369

Review 3.  Exercise and Aerobic Fitness to Reduce Cancer-Related Cardiovascular Toxicity.

Authors:  Umberto Campia; Ana Barac
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-07

4.  Peripheral Microvascular Function Reflects Coronary Vascular Function.

Authors:  Ahmed Al-Badri; Jeong Hwan Kim; Chang Liu; Puja K Mehta; Arshed A Quyyumi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04-25       Impact factor: 8.311

5.  Contribution of endothelium-derived hyperpolarizing factor to exercise-induced vasodilation in health and hypercholesterolemia.

Authors:  Muhiddin A Ozkor; Salim S Hayek; Ayaz M Rahman; Jonathan R Murrow; Nino Kavtaradze; Ji Lin; Amita Manatunga; Arshed A Quyyumi
Journal:  Vasc Med       Date:  2015-02-03       Impact factor: 4.739

6.  Sex-specific effects of cardiovascular risk factors on endothelium-dependent dilation and endothelin activity in middle-aged women and men.

Authors:  Vijaywant Brar; Sartaj Gill; Carmine Cardillo; Manfredi Tesauro; Julio A Panza; Umberto Campia
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

7.  Endothelial cyclooxygenase-1 paradoxically drives local vasoconstriction and atherogenesis despite underpinning prostacyclin generation.

Authors:  Jane A Mitchell; Fisnik Shala; Maria Elisa Lopes Pires; Rachel Y Loy; Andrew Ravendren; Joshua Benson; Paula Urquhart; Anna Nicolaou; Harvey R Herschman; Nicholas S Kirkby
Journal:  Sci Adv       Date:  2021-03-19       Impact factor: 14.136

8.  Effect of Triflusal on Primary Vascular Dysregulation Compared with Aspirin: A Double-Blind, Randomized, Crossover Trial.

Authors:  Sanghoon Shin; Kwang-Joon Kim; In-Jeong Cho; Geu-Ru Hong; Yangsoo Jang; Namsik Chung; Young Min Rah; Hyuk-Jae Chang
Journal:  Yonsei Med J       Date:  2015-09       Impact factor: 2.759

9.  Cyclooxygenase inhibition improves endothelial vasomotor dysfunction of visceral adipose arterioles in human obesity.

Authors:  Melissa G Farb; Stephanie Tiwari; Shakun Karki; Doan T M Ngo; Brian Carmine; Donald T Hess; Maria A Zuriaga; Kenneth Walsh; Jessica L Fetterman; Naomi M Hamburg; Joseph A Vita; Caroline M Apovian; Noyan Gokce
Journal:  Obesity (Silver Spring)       Date:  2013-07-29       Impact factor: 5.002

Review 10.  Interactions between the Cyclooxygenase Metabolic Pathway and the Renin-Angiotensin-Aldosterone Systems: Their Effect on Cardiovascular Risk, from Theory to the Clinical Practice.

Authors:  Jakub Gawrys; Karolina Gawrys; Ewa Szahidewicz-Krupska; Arkadiusz Derkacz; Jakub Mochol; Adrian Doroszko
Journal:  Biomed Res Int       Date:  2018-10-02       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.